9-99227663-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_006808.3(SEC61B):c.102-236A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0615 in 152,260 control chromosomes in the GnomAD database, including 335 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.062 ( 335 hom., cov: 32)
Consequence
SEC61B
NM_006808.3 intron
NM_006808.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Publications
2 publications found
Genes affected
SEC61B (HGNC:16993): (SEC61 translocon subunit beta) The Sec61 complex is the central component of the protein translocation apparatus of the endoplasmic reticulum (ER) membrane. Oligomers of the Sec61 complex form a transmembrane channel where proteins are translocated across and integrated into the ER membrane. This complex consists of three membrane proteins- alpha, beta, and gamma. This gene encodes the beta-subunit protein. The Sec61 subunits are also observed in the post-ER compartment, suggesting that these proteins can escape the ER and recycle back. There is evidence for multiple polyadenylated sites for this transcript. [provided by RefSeq, Jul 2008]
SEC61B Gene-Disease associations (from GenCC):
- polycystic liver disease 1Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- SEC61B-related polycystic liver diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 9-99227663-A-G is Benign according to our data. Variant chr9-99227663-A-G is described in ClinVar as [Benign]. Clinvar id is 1241775.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0767 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0614 AC: 9348AN: 152142Hom.: 334 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9348
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0615 AC: 9366AN: 152260Hom.: 335 Cov.: 32 AF XY: 0.0603 AC XY: 4488AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
9366
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
4488
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
1636
AN:
41570
American (AMR)
AF:
AC:
968
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
189
AN:
3468
East Asian (EAS)
AF:
AC:
53
AN:
5184
South Asian (SAS)
AF:
AC:
286
AN:
4830
European-Finnish (FIN)
AF:
AC:
579
AN:
10586
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5333
AN:
68000
Other (OTH)
AF:
AC:
134
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
427
854
1280
1707
2134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
154
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 17, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.